New multiple sclerosis severity model predicts future accumulation of disability (P1.373)

Conclusions:This represents a much needed tool for genotype-phenotype correlations, for identifying biological processes that underlie MS progression, and for aiding clinicians and patients in therapeutic decisions.Study Supported by: Intramural research program of NIH/NINDSDisclosure: Dr. Bielekova received patent royalty payments from National Institutes of Health. Dr. Barbour has nothing to disclose. Dr. Tapia Maltos has nothing to disclose. Dr. Weideman has nothing to disclose. Dr. Kosa has nothing to disclose. Dr. Komori has nothing to disclose. Dr. Johnson has nothing to disclose. Dr. Greenwood has nothing to disclose.

Source: Neurology - April 17, 2017 Category: Neurology Authors: Bielekova, B., Barbour, C., Maltos, M. T., Weideman, A., Kosa, P., Komori, M., Johnson, K., Greenwood, M. Tags: Tools and Measures for Clinical Evaluation in Multiple Sclerosis Source Type: research